Glibenclamide + Metformin stimulate insulin secretion from pancreatic β-cells, reduce glucose output from the liver and increase insulin sensitivity at peripheral target sites.
Glibenclamide + Metformin stimulate insulin secretion from pancreatic β-cells, reduce glucose output from the liver and increase insulin sensitivity at peripheral target sites.
Glibenclamide + Metformin is used in the treatment of Type 2 Diabetes Mellitus.
Glibenclamide + Metformin should not be given in patients with the following conditions:
Glibenclamide + Metformin may have the following side effects:
Precautions
Take precautions in people with the following conditions:
Interactions
Glibenclamide + Metformin may interact with the following medicines:
Symptoms of overdose include:
Seek medical help immediately.
Available Brands:
Aviglen-forte, Aviglen MF, Ben-Q-Met, Ben-Q-Met Forte, Ben-Q-Met LS, Benclamet, Benclamet Forte, Benformin, Benformin HS
UsesWarningsSide EffectsPrecautionsOverdose & BrandsUses Ultravist is used in the following conditions: Radiographic Imaging: Iopromide injection is utilized to enhance the [...]
UsesWarningsSide EffectsPrecautionsOverdose & BrandsUses Ultramox is used in the following conditions: Respiratory Infections: Amoxicillin is often used to treat respiratory [...]
UsesWarningsSide EffectsPrecautionsOverdose & BrandsUses Ultraliv is used in the following conditions: Carnitine Orotate: Carnitine orotate is a combination of L-carnitine [...]